You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
67 search results for: guidelines
expert video
La DA en pacientes pediátricos: Novedades en el abordaje terapéutico de la Dermatitis Atópica en niños a partir de 6 meses de edad
Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Lucero Noguera, dermatóloga en el Hospital Infantil Universitario Niño Jesús nos presenta las novedades en el abordaje terapéutico de la dermatitis atópica pediátrica.
La DA en pacientes pediátricos: Entendiendo la Dermatitis Atópica en la población infantil
Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Sara Palencia, dermatóloga en el Hospital Universitario 12 de Octubre, que nos habla sobre la dermatitis atópica en la población infantil.
La DA en pacientes pediátricos: Experiencia con Dupilumab
Dermatology
En esta tercera escala de ADVENT ON TOUR en MADRID contamos con la Dra. Marta Feito, dermatóloga en el Hospital Universitario La Paz, presentó su experiencia con Dupilumab.
ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.
For healthcare professionals in Algeria: Please read the additional Terms of Use.
Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.